Pharmacy

Moderna’s new combination vaccine for seasonal influenza and COVID-19 has outperformed current standard vaccines in a large phase 3 clinical trial, showing stronger immune responses to both viruses in adults 50 years or older.  The findings, published May 7 in…

A new fixed-dose combination therapy pairing obicetrapib with the cholesterol-lowering drug ezetimibe significantly reduced low-density lipoprotein (LDL) cholesterol levels in patients whose cholesterol remained elevated despite statin use, according to research published in The Lancet. The randomized, double-blind study enrolled…

The FDA is ramping up oversight of foreign manufacturing sites by expanding its use of unannounced inspections, a move aimed at leveling the playing field between domestic and international drugmakers, according to a May 6 news release from the agency. …

A new study showed that the experimental drug lorundrostat led to reductions in blood pressure in patients with uncontrolled hypertension already taking multiple medications.  The randomized, placebo-controlled trial, the results of which were published April 23 in The New England…

The most expensive drug category for nonfederal hospitals in 2024 were antineoplastic targeted agents, according to a study published in the American Journal of Health-System Pharmacy.  The report, published by the American Society of Health-System Pharmacists, found that U.S. drug…

The FDA has approved Johnson & Johnson’s drug Imaavy for the treatment of generalized myasthenia gravis, a chronic autoimmune neuromuscular disorder.  The approval covers adults and pediatric patients 12 and older who test positive for anti-acetylcholine receptor or anti-muscle-specific kinase…

Sens. Josh Hawley, R-Mo., and Peter Welch, D-Vt., introduced a bipartisan bill intended to lower prescription drug prices in the U.S. by tying them to international pricing.  The Fair Prescription Drug Prices for Americans Act would prohibit pharmaceutical companies from…

The FDA’s leader of drug and food inspections, imports and investigations abruptly announced he plans to exit the agency next week, according to a May 5 CBS News report.  Michael Rogers, associate commissioner for inspections and investigations, told staff his…

On May 5, President Trump signed an executive order aimed at boosting domestic production of prescription drugs and active ingredients. Six details: 1. In the U.S., bringing new drug manufacturing plants online can take years, “which is unacceptable from a…

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. Editor’s note: The drugs listed are in alphabetical order.